SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

9 Months Ended

Sep. 30, 2012

Schedule Of Net Sales And Operating Income By Reportable Segment

Net sales and profit by reportable segment for the three and nine months ended September 30, 2012 and 2011 are as follows:



	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011
	(In thousands)
Segment Net Sales
U.S. Neurosurgery	$	43,269		$	42,800		$	125,776		$	122,246
U.S. Instruments	41,469			41,543			120,732			116,932
U.S. Extremities	32,961			24,825			91,596			69,341
U.S. Spine and Other	49,188			48,293			142,821			128,885
International	43,197			44,724			135,514			139,151
Total revenues	$	210,084		$	202,185		$	616,439		$	576,555
Segment Profit
U.S. Neurosurgery	$	23,201		$	22,624		$	66,247		$	62,489
U.S. Instruments	9,293			8,779			26,259			22,029
U.S. Extremities	14,996			9,657			37,484			27,692
U.S. Spine and Other	14,771			13,390			42,166			38,576
International	14,550			14,721			45,456			48,911
Segment profit	76,811			69,171			217,612			199,697
Amortization	(4,618)			(4,548)			(13,985)			(11,609)
Corporate and other	(52,457		)	(46,332		)	(148,403		)	(140,925		)
Operating income	$	19,736		$	18,291		$	55,224		$	47,163

Revenues By Market Category

Revenue by major product category consisted of the following:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
	(In thousands)
Orthopedics	$	94,186	$	85,698	$	276,033	$	239,429
Neurosurgery	69,667		69,768		203,499		203,129
Instruments	46,231		46,719		136,907		133,997
Total Revenues	$	210,084	$	202,185	$	616,439	$	576,555

Total Revenue By Major Geographic Area

Total revenue by major geographic area consisted of the following:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
	(In thousands)
United States	$	165,930	$	156,530	$	478,087	$	434,324
Europe	20,351		21,839		66,903		72,203
Rest of World	23,803		23,816		71,449		70,028
Total Revenues	$	210,084	$	202,185	$	616,439	$	576,555

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details